Skip to main content
Back to Creative Destruction Lab

Creative Destruction Lab's Therapeutics Portfolio

Browse 11 Therapeutics companies funded by Creative Destruction Lab. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
11
Total Funding in Therapeutics
$244.6M

Therapeutics Portfolio Companies (11)

Export
BiotechnologyHealth CareLife ScienceTherapeutics

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.

San Francisco, United States
September 2022
$3.0M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGeneticsTherapeutics

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.

Toronto, Canada
July 2021
$180.0M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyTherapeutics

Exin Therapeutics offers next-gen neurotherapeutics leverage machine learning, genome editing, & bioelectronic medicine.

South San Francisco, United States
July 2026
$500K
Non-equity Assistance

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyChemicalHealth CareLife ScienceMachine LearningPharmaceuticalQuantum ComputingTherapeutics

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

Palo Alto, United States
May 2023
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

Boston, United States
March 2022
$7.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareNeuroscienceTherapeutics

Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.

San Diego, United States
February 2025
$4.0M
Grant

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Machine LearningPharmaceuticalTherapeutics

Valence Discovery (“Valence”), is an AI-first design of novel chemistry against previously intractable biology.

Montréal, Canada
December 2021
$7.0M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

Toronto, Canada
December 2023
$50K
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Mesentech is a company focused on treating diseases and medical conditions that relate to bone.

Vancouver, Canada
January 2023
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsTherapeutics

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases

Oxford, United Kingdom
October 2022
$42.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeutics

CereCura Nanotherapeutics is developing novel RNA therapeutics for central nervous system disorders.

Vancouver, Canada
November 2025
$998K
Seed

Founder Contacts

30,000+ verified contacts

Explore Creative Destruction Lab's Full Portfolio

View all companies funded by Creative Destruction Lab across every industry and funding stage.

View Full Creative Destruction Lab Portfolio